2016
DOI: 10.1536/ihj.16-038
|View full text |Cite
|
Sign up to set email alerts
|

Thrombectomy and Catheter-Directed Thrombolysis Combined With Antithrombin Concentrate for Treatment of Antithrombin Deficiency Complicated by Acute Deep Vein Thrombosis That Is Refractory to Anticoagulation

Abstract: SummaryA 22-year-old male was admitted to our hospital with deep vein thrombosis that was complicated by antithrombin deficiency. This deficiency was refractory to anticoagulation therapy. Although catheter-directed thrombolysis could not reperfuse the total occlusion in the left deep vein, a combination of thrombectomy, catheter-directed thrombolysis, and antithrombin concentrate treatment was able to dissolve the clots and ameliorate the blood flow into the left deep vein. Antithrombin concentrate administra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…AT III deficiency and APS are both typically managed with vitamin K antagonists [ 3 , 8 ]. Although our patient did not meet the criteria for a definitive diagnosis of APS or CAPS, we managed her similarly to patients diagnosed with said conditions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…AT III deficiency and APS are both typically managed with vitamin K antagonists [ 3 , 8 ]. Although our patient did not meet the criteria for a definitive diagnosis of APS or CAPS, we managed her similarly to patients diagnosed with said conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Various acquired causes may include decreased production and increased consumption, such as in liver disease, nephrotic kidney disease, or enteropathic protein loss. Most commonly, AT III deficiency leads to venous thromboemboli (VTE) of the deep veins and pulmonary vessels, leading to a seven-fold increased risk of VTE [ 2 , 3 ]. As with most inherited thrombophilia syndromes, warfarin is an acceptable anticoagulant for VTE prevention; however, strict anticoagulation is required, which makes the treatment difficult for some patients.…”
Section: Introductionmentioning
confidence: 99%